Ann: First patient enrolled in CHM CDH17 Phase 1/2 clinical trial, page-19

Looking at the most recent pipeline, there is a swag of trials in progress not just four, Dalts. Although, in saying that, perhaps my interpretation is skewed - I got used to referencing the old version which had loads more details pertaining to the individual trials.

Throw in the Phase "1-slash-2" specification for the CDH17 trials... and the range and calibre of trials has to be considered incredible. There are also four studies in the lab! Bring on the marketing alongside the preclinical and clinical data and hopefully the necessary dilution will be minimised.



Btw, its not CHM that needs her mojo back! It's Mr Market who needs to let up and share some joy!, the tight arse!!